A risk calculator predicting recurrence in lymph node metastatic penile cancer.

Marco BandiniPhilippe E SpiessFilippo Pederzoli Laura Marandino Oscar R BrouwerMaarten AlbersenEduard RousselHielke M de VriesJuan J Chipollini Yao ZhuDing-Wei YeAntonio Augusto OrnellasMario CatanzaroOliver W HakenbergAxel HeidenreichFriederike HaidlNick WatkinMichael AgerMohamed E AhmedRobert Jeffrey KarnesAlberto BrigantiRoberto SalvioniFrancesco MontorsiMounsif Azizi Andrea Necchi

Published in: BJU international (2020)

Adjuvant treatment planning is crucial in patients with pSCC with ILNM, where only weak evidence is available. The current tool proved to successfully stratify patients according to their individual risk, potentially allowing better tailoring of adjuvant treatments.

Keyphrases

lymph node
early stage
end stage renal disease
papillary thyroid
peritoneal dialysis
prognostic factors
prostate cancer
neoadjuvant chemotherapy
patient reported outcomes
sentinel lymph node
patient reported
radical prostatectomy
childhood cancer